Like all antidepressant, Seroxat has the secondary effect well known of doctors, but
their prescription reflect a huge market for laboratory with important financial stake. The development of one molecule represent further billions dollars of investment. Like everywhere in the world the sanitary authorities realize with the laboratory a battery of test before his launching on the market.
But the tests aren’t sufficiently pushed following the women pregnant and especially for their future baby. The test realize in 1991 on the animals threathen to Seroxat don’t appear reassuring even if the numbers of animals present one symptom represent almost nothing. The human test effectuate by GSK present risks for the health of the child. The risk of birth defects exists. The fœtus and as the future baby risks major congenital malformations, persistent pulmonary hypertension or again convulsions according to a study realize by FDA (Foods and Drugs Administration) in 2003. The risk for the women pregnant has been increased passing by Category C to D.
Even if they aren’t question to stop
treatment during
pregnancy, the replacement of treatment isn’t always a good solution. The women who are not stopping their treatment are less chance to relapse. But their doctor warns watch with attention the alimentation and weight gain of their patient. All substance that absorb during pregnancy can be transmit to your future child.
Alcohol, tobacco, medicine, and diverse drugs susceptible to be transmit to your baby. But you don’t forget that your mood during pregnancy can play a serious role in the future development of your child.